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Abstract
Background: We investigated the reporting and methods of prediction studies, focusing on aims, designs, participant
selection, outcomes, predictors, statistical power, statistical methods, and predictive performance measures.
Methods and Findings: We used a full hand search to identify all prediction studies published in 2008 in six high impact
general medical journals. We developed a comprehensive item list to systematically score conduct and reporting of the
studies, based on recent recommendations for prediction research. Two reviewers independently scored the studies. We
retrieved 71 papers for full text review: 51 were predictor finding studies, 14 were prediction model development studies,
three addressed an external validation of a previously developed model, and three reported on a model’s impact on
participant outcome. Study design was unclear in 15% of studies, and a prospective cohort was used in most studies (60%).
Descriptions of the participants and definitions of predictor and outcome were generally good. Despite many
recommendations against doing so, continuous predictors were often dichotomized (32% of studies). The number of
events per predictor as a measure of statistical power could not be determined in 67% of the studies; of the remainder, 53%
had fewer than the commonly recommended value of ten events per predictor. Methods for a priori selection of candidate
predictors were described in most studies (68%). A substantial number of studies relied on a p-value cut-off of p,0.05 to
select predictors in the multivariable analyses (29%). Predictive model performance measures, i.e., calibration and
discrimination, were reported in 12% and 27% of studies, respectively.
Conclusions: The majority of prediction studies in high impact journals do not follow current methodological
recommendations, limiting their reliability and applicability.
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Introduction
In recent years there has been an increasing interest in the
methodology of prediction research [1–16]. Prediction research
includes both diagnostic prediction studies studying the ability of
variables or test results to predict the presence or absence of a
certain diagnosis, and prognostic studies studying predictors of the
future occurrence of outcomes [6,11,15]. Both types of prediction
research may include single variable (or predictor or test) studies,
multivariable studies aimed at finding the independently contrib-
uting predictors among multiple candidate predictors, or the
development, validation, or impact assessment of multivariable
prediction models. Many have stressed the importance of pre-
defining the key aspects of a study, including aims, study design,
study population, clinically relevant outcomes, candidate predic-
tors, sample size considerations, and statistical analysis. Use of
poor methods may lead to biased results [2,7,10,12,13,15,17–32].
We performed a comprehensive literature review of articles
published in high impact general medical journals to assess
whether prediction research in the recent literature was conducted
according to methodological recommendations. We considered all
types of clinical prediction studies and all methodological issues
that are considered to be important in prediction research, rather
than on specific types of outcomes [33], specific methodological
issues [34], or specific disease areas [20,21,35–37]. We focus on
the reporting of aim, design, study sample, definition and
measurement of outcomes and candidate predictors, statistical
power and analyses, model validation, and results, including
predictive performance measures.
Methods
Literature Search
We fully hand searched the six highest impact (based on Web of
Knowledge impact factors) general medicine journals for the year
2008 (Figure 1). We excluded all studies that were not original
research (e.g., editorials, letters) or had no abstract. One reviewer
(W. B.) examined titles and abstracts of citations to identify
prediction studies. The full text of all thus selected studies was
obtained, and two authors (W. B. and N. P. A. Z.) independently
assessed eligibility; in case of doubt a third independent reader was
involved (K. G. M. M. or Y. V.).
Inclusion Criteria
We focused on multivariable prediction studies that were
defined as descriptive studies where the aim was to predict an
outcome by two or more independent variables, i.e., a causal
relationship between independent variable(s) and outcome was not
necessarily assumed [6,11]. We included both diagnostic and
prognostic multivariable prediction studies. We excluded studies
that investigated a single predictor, test, or marker (such as single
diagnostic test accuracy or single prognostic marker studies),
studies that investigated only causality between one or more
variables and an outcome, and studies that could not contribute to
patient care, e.g., predictor finding studies to predict citation
counts.
Development of Item List
We developed a comprehensive item list based on the existing
methodological recommendations for conducting and reporting
prediction research, and on extensive discussions among the co-
authors. To this aim we studied existing reporting statements and
checklists (e.g., CONSORT, REMARK, STARD, and STROBE)
and quality assessment tools from other domains (e.g., QUADAS)
for those aspects that also pertain to multivariable prediction
studies, e.g., study aims, design, and participant selection [4,38–
41]. Further, to identify additional aspects relevant for good
conducting and reporting of multivariable prediction research, we
consulted published recommendations for prediction research and
the references of these studies [1–10,12–16,20,21,27,28,42–44].
Data Extraction
Data were extracted to investigate both the reporting of and use
of methods known to influence the quality of multivariable
prediction studies. The main items that we extracted are
summarised in Box 1. For investigation of statistical power in
prediction studies, we considered the individual multivariable
models within studies, because power differed among models
within a single study.
Items were scored as present, absent, not applicable, or unclear.
If an item concerned a numeric value (e.g., the number of
participants) we extracted this value. If a description was unclear,
we classified it as not described or separately reported it in our
tables. If studies referred to other papers for detailed descriptions,
the corresponding items were checked in those references.
Two authors (W. B., N. P. A. Z.) independently extracted the
data. In case of doubt, items were discussed with a third and fourth
reviewer (K. G. M. M., Y. V.). The inter-reviewer agreement on
the data extraction was assessed by calculating the percentage of
overall agreement between the two reviewers.
Analysis
We distinguished five types of multivariable prediction research.
Predictor finding studies. These studies aim to explore
which predictors out of a number of candidate predictors
independently contribute to the prediction of, i.e., are associated
with, a diagnostic or prognostic outcome [3,6,28].
Model development studies without external valida-
tion. These studies aim to develop a multivariable prediction
model, e.g., for use in practice to guide patient management. Such
studies aim to identify the important predictors, assign the
(mutually adjusted) weights per predictor in some kind of
multivariable analysis, and develop a final multivariable prediction
model [6,7]. These studies might include internal validation
studies, such as random split-sample methods, cross-validation, or
bootstrapping [43].
Model development studies with external validation. These
studies have the same aim as the previous type but also test the
performance of the developed model in a so-called external dataset
from, e.g., another time period (temporal validation) or another
hospital, country, or setting (geographical validation). Explicit
withholding of the data from some study centres for validation was
also considered as (geographical) external validation.
External validation studies without or with model
updating. These studies aimed to assess the performance of a
previously reported prediction model using new participant data
that were not used in the development process, and in some cases
adjusted or updated the model based on the validation data when
there was poor validation [8–10,45–47].
Model impact studies. These studies aim to quantify the
effect or impact of using a prognostic or diagnostic prediction
model on patient or physician behaviour and management,
patient health outcomes, or cost-effectiveness of care, relative to
not using the model [9,45,48].
We grouped results by type of multivariable prediction research,
medical specialty (oncology, cardiovascular diseases, other), and
whether the prediction analysis was a primary or secondary study
aim.
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Ethics Statement
An ethics statement was not required for this work.
Results
We identified 1,204 articles by hand searching, of which 71 met
the inclusion criteria (Figure 1 and Text S2). Most studies were
excluded based on title or abstract. It was difficult to distinguish,
from study abstracts alone, between descriptive predictor finding
studies and articles studying causality of a factor. We thus read 104
full text papers, excluding 50 studies deemed causal (Figure 1). The
PRISMA checklist is provided as Text S1.
Data Extraction and Reviewer Agreement
The two reviewers agreed on a median of 92% (interquartile
range 75%–100%) of the items extracted. Most discrepancies
related to specific participant sampling strategies or participant
sources and were resolved after discussion with a third reviewer.
The main challenge was to distinguish between predictor
finding and model development studies. Authors in general did
not explicitly state their aim, so we used full text interpretations
to classify studies as predictor finding or model development
studies.
Study Aims
Most multivariable prediction studies were published in the field
of cardiovascular diseases (n=24) (Table 1). The aim was usually
to identify independently contributing predictors of an outcome
(n=51/71). Of the prediction modelling studies (n=20), the vast
majority were model development studies, without (n=11) or with
(n=3) external validation. Pure external validation (n=3) and
impact studies (n=3) were rare. There were few multivariable
diagnostic studies (n=5). In the 71 publications, 135 models or sets
of predictors were studied. For example, in predictor finding
studies a search for independently contributing predictors might
be applied across different participant subgroups (e.g., males
versus females) for multiple outcomes, and in prediction modelling
studies, more than one model might be developed or validated
(e.g., for different outcomes or presenting a basic and extended
model).
Design of Participant Sampling
A cohort, nested case-control, or case-cohort design is
commonly recommended for prognostic and diagnostic model
development and validation [6]. A prospective cohort is prefer-
able, because it enables optimal measurement of predictors and
outcome. A retrospective cohort may allow for a longer follow-up
period but usually at the expense of poorer data [6]. Randomized
trial data have advantages similar to those of prospective cohort
data, unless restrictive eligibility criteria make the study sample
unrepresentative. Further, treatments proven to be effective in the
trial should be included or adjusted for in the modelling. Cohort,
nested case-control and case-cohort datasets each allow for
calculation of absolute outcome risk [6,18,49]. A non-nested
Figure 1. Flowchart of included studies. aThe hand search included only studies with an abstract, published in 2008 in The New England Journal
of Medicine, The Lancet, JAMA: the Journal of the American Medical Association, Annals of Internal Medicine, BMJ, and PLoS Medicine. The following
publication types were excluded beforehand: editorials, bibliographies, biographies, comments, dictionaries, directories, festschrifts, interviews,
letters, news, and periodical indexes. bStudies, generally conducted in a yet healthy population, aimed at quantifying a causal relationship between a
particular determinant or risk factor and an outcome, adjusting for other risk factors (i.e., confounders). cFor example, see [72].
doi:10.1371/journal.pmed.1001221.g001
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case-control design may, however, be sufficient for predictor
finding studies, since these studies generally do not aim to calculate
absolute risks.
We found that case-control designs were indeed used only by
predictor finding studies (Table 2). Prospective cohort data, either
observational or randomized trial data, were most frequently used
(n=44). Quantifying the impact of a prediction model on
participant outcome requires a comparative study design [9,48].
A randomized trial was used by two of the three impact studies;
the third used an observational before-after (prospective) cohort
design, comparing participant outcomes before and after the
introduction of a prediction model.
Participant Recruitment, Follow-Up, and Setting
Participant recruitment was in general well described. Inclusion
criteria were reported in 64/71 studies. Description of the cohort
characteristics was clear in 68/69 of the relevant prediction studies
(not applicable for two non-nested case-control studies). Study
recruitment dates were reported in 88% of the studies. Length of
follow-up was not reported in nine studies, leaving readers unable
to know the time period for the predicted risks of the models.
Whether (all) consecutive participants were included or how many
participants refused to participate was rarely reported and so could
not be evaluated. The majority of studies involved participants
from a hospital setting (38%) or the general (healthy) population
(27%). Clinical setting was not reported in 4% of the studies.
Outcome
In outcome reporting, we expected differences between studies
with prediction as a primary versus a secondary aim, but this was
not observed. Outcomes were well defined in 62/68 studies
(Table 3). However, only 12 studies reported that they blinded the
outcome measurement for predictor values. Knowledge of the
predictors might influence outcome assessment, resulting in a
biased estimation of the predictor effects for the outcome
[6,17,39]. 11/68 studies had all cause mortality as the outcome,
where such bias would not be a factor.
Most studied outcomes were binary or time-to-event outcomes.
Some outcomes are binary per se, but in some studies, continuous,
categorical, and time-to-event data were analyzed as binary
outcomes, a practice that is not recommended because less
accurate predictions are likely to result, as with dichotomizing
predictor variables [50].
Prediction of more than one outcome was very common in
predictor finding studies, apparently because of their exploratory
aim (Table S1). However, selective reporting of outcomes (and
Table 1. Aim of the included multivariable prediction studies, subdivided by clinical domains.
Study Aim
Cardiovascular
(n=24)
Oncology
(n=13)
Othera
(n=34)
Total
Papers
(n=71)
Number of
Models
(n=135)
Number of
Diagnostic
Studies
Predictor finding studies
Prediction was primary aim 46 (11) 62 (8) 44 (15) 48 (34) 49 (66) 1
Prediction was secondary aim 17 (4) 31 (4) 26 (9) 24 (17) 21 (28) 0
Prediction model development without external validation 21 (5) 8 (1) 15 (5) 15 (11)b 14 (19) 1
Prediction model development with external validation 4 (1) 0 (0) 6 (2) 4 (3) 8 (11) 0
External validation, without updating a prediction modelb 8 (2) 0 (0) 3 (1) 4 (3) 5 (7) 1
Impact assessment of a prediction model 4 (1) 0 (0) 6 (2) 4 (3) 3 (4) 2
Numbers are column percentages, with absolute numbers in parentheses.
aIncluding studies from infectious diseases (n=7), diabetes (n=5), neonatology and child health (n=6), mental disorders (e.g., dementia) (n= 4), and musculoskeletal
disorders (e.g., lower back pain) (n= 4).
bThere were no external validation studies of a previously published model that also updated the model after poor validation.
doi:10.1371/journal.pmed.1001221.t001
Box 1. Overview of Items Addressed in This
Review
Study design Type of prediction study (e.g., model
development); participant sampling or selection method
(e.g., cohort, case-control approach)
Participants Participant recruitment; follow-up; inclusion
and exclusion criteria; setting (e.g., primary or secondary
care or general population)
Candidate predictors Clear definition to ensure repro-
ducibility; coding of predictor values; assessment blinded
for outcome
Outcome Clear definition to ensure reproducibility; type
of outcome; assessment blinded for predictors
Statistical power Effective sample size (e.g., number of
outcome events compared to number of candidate
predictors)
Selection of predictors Selection of predictors prior to
statistical analysis and within statistical analysis; use of
variable selection strategies (e.g., backward selection);
criterion for predictor inclusion (e.g., p,0.05)
Handling of missing values Reporting of missing values
per predictor, or number or percentage of participants
with missing values; reporting of procedures for dealing
with missing values
Presentation of results Reporting of univariable and
multivariable predictor–outcome effects; reporting of full
or final model
Model performance measures and validation Type
of predictive performance measures reported (e.g., C-
statistic and calibration); type of validation (e.g., internal or
external)
Reporting and Methods in Prediction Research
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predictors) is often a risk [51]. Unfortunately, study registration is
not mandated for prediction research, so it is generally impossible
to assess whether some outcomes were analysed but not reported.
A number of studies predicted a combined endpoint (14/71).
The use of a combined endpoint will give problems if the predictor
effect is in opposite directions for different outcomes included in
the composite endpoint [52,53].
Candidate Predictors
Description of the candidate predictor variables was in general
clear (59/68) (Table 4). In 51 of the 68 studies, predictor
measurement was blinded for the outcome: in 44, simply because
of the prospective design; in seven non-prospective studies,
predictor measurement was explicitly blinded for the outcome.
One study also assessed the predictors independently, i.e., the
predictors that were studied for whether they added value to an
existing model were assessed without knowledge of the predictors
in that model. Predictor interaction (non-additivity) was tested in
25 of the 51 predictor finding studies and in 11 of the 14 model
development studies (total n=36). Dichotomization of continuous
predictors is still common practice (21/64), despite being
discouraged for decades [3,50].
Statistical Power
For assessment of statistical power in studies estimating
predictor effects for binary or categorical event outcomes, the
number of participants in the smallest group determines the
effective sample size. A frequently mentioned rule of thumb is ‘‘10
events needed per candidate predictor’’ [12,25,26,30,54]. For
time-to-event outcomes, the effective sample size is also highly
related to the number of participants who experience the event
[12]. For continuous outcomes, the effective sample size is
determined by the number of participants included in the linear
regression analysis.
The number of candidate predictors should include all variables
initially considered in the study as potential predictors, and not
only those considered or included in the multivariable analysis.
The candidate predictors also include the number of predictor
Table 2. Study design in relation to study aim.
Study Design
Total
(n=71)
Predictor Finding
Studies (n=51)
Development without
External Validation
(n=11)
Development with
External Validation
(n=3)
External Validation
(without Updating)
(n=3)
Impact
Analysis
(n=3) Specifications (n)
Prospective
cohorta
62 (44) 53 (27) 82 (9) 100 (3) 67 (2) 100 (3) Cross-sectional (1)
Randomized trial
(13)b
Retrospective
cohorta
14 (10) 16 (8) 9 (1) 0 (0) 33 (1) 0 (0) Cross-sectional (2)
Case-controlc 8(6) 12 (6) 0 (0) 0 (0) 0 (0) 0 (0) Nested (4)
Non-nested (2)
Not described
or unclear
15 (11) 20 (10) 9 (1) 0 (0) 0 (0) 0 (0)
Numbers are column percentages, with absolute numbers in parentheses, except for the column ‘‘Specifications’’, which includes only absolute numbers.
aSome cohort studies had a cross-sectional cohort design, which was possible because the predictor values did not change (gender, genes, etc.) or because the study
involved a diagnostic prediction model study.
bOf the 13 studies that used randomized trial data, 11 were predictor finding or model development studies. Of these 11 studies, five adjusted for the treatment effect,
three did not adjust because there was no treatment effect, one did not adjust despite an effective treatment, and in two studies reporting and adjustment for
treatment effects was entirely missing.
cOne study used two designs: a cross-sectional case-cohort and a cross-sectional nested case-control (here both scored as nested case-control).
doi:10.1371/journal.pmed.1001221.t002
Table 3. Reporting of outcomes.
Reporting and Analysis of Outcomes Percentage (n)
Clear definition 91 (62)
Assessment blinded for predictorsa 22 (12)
Type of outcome describedb 93 (63)
Continuous 9 (6)
Linear regression 83 (5)
Logistic regressionc 17 (1)
Binary 34 (23)
Logistic regression 91 (21)
Non-regressiond 9 (2)
Categorical 12 (8)
Polytomous regression 38 (3)
Logistic regression 50 (4)
CART 13 (1)
Time to event 48 (30)
Survival analysis 97 (29)
Logistic regression 3 (1)
Impact studies were excluded from this table because these studies had
outcomes of a different type (e.g., costs). Hence, the total number of studies is
68.
aNot applicable in 11/68 studies, because all cause death was the outcome.
bTypes of outcomes and how they were analysed (unclear for five studies). The
sum 6+23+8+30 is higher than 63 because some outcomes were analysed in
more than one way (e.g., a time-to-event outcome that was analysed as time to
event and as a binary outcome neglecting time). If a study analysed two binary
outcomes, it was here counted as one binary outcome.
cAfter dichotomization of a continuous outcome.
dOne study used the Cochran–Mantel–Haenszel procedure, another calculated
odds ratios.
CART, classification and regression tree.
doi:10.1371/journal.pmed.1001221.t003
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interactions tested and the number of dummy variables used to
include a categorical predictor in a model.
For predictor finding and model development studies, we
calculated the statistical power of the fitted models based on (1) the
number of predictors eventually included in the final model and (2)
the number of candidate predictors (Table 5). Based on the
former, as expected, the statistical power was indeed .10 events
per variable in 84 (11+60+1+13) of the 124 (96+28) models fitted
in these studies. However, there was insufficient reporting of the
number of candidate predictors in the vast majority of these
studies, such that a proper estimation of the statistical power could
not be made. In the studies that clearly described the number of
candidate predictors, the effective sample size was ,10 events per
variable in 50% (n=21) of the presented models.
To externally validate a prediction model, a minimum effective
sample size of 100 participants with and 100 without the event has
been recommended [55]. Given this, effective sample size was
sufficient in the majority of the external validation studies (9/13
models).
Across all 71 included prediction studies, only 12 gave an
explicit sample size calculation.
Selection of Candidate and Final Predictors
Adequate reporting of predictor selection methods used is
important, because the number of candidate predictors and how
they were selected at various stages of the study can both influence
the specific predictors included in the final multivariable model, and
thus affect the interpretation of the results [12,13,43,56]. This issue
is not specific to prediction studies but also arises in causal research,
although here variables to be included in the multivariable
modelling are usually referred to as confounders. Ideally, candidate
predictors are selected based on theoretical or clinical understand-
ing. There is no clear cut method that is widely recommended to
select independent variables from candidate variables. However,
many methodological reports have shown that selection based on
(significant) univariable predictor–outcome associations is not
recommended, as this method increases the chance of biased results
in terms of spurious predictors and overfitted and unstable models
[12,13,43,56]. In multivariable analyses, predictors are most often
selected based on backward or forward selection, typically using a
significance level of 0.05. However, the use of multivariable
selection methods can also lead to overfitting and unstable models,
especially when there are relatively few outcome events and many
predictors analysed [10,12,13].
We found that selection of candidate predictors was described
for 36 (75%) of the studies where prediction was the primary
aim and for eight (47%) of the studies where prediction was a
secondary aim (Table 6). In studies with prediction as the
primary aim, the majority (71%) selected their candidate
predictors based on existing literature, whereas this was less
often the case (29%) in studies with prediction as a secondary
aim.
Pre-selection of candidate predictors for inclusion in the
multivariable analyses based on univariable predictor–outcome
associations was used in 13% of the primary-aim and in 24% of
the secondary-aim prediction studies.
The method of selection of predictors within multivariable
models was not described in 19% of the studies. Studies reported
using backward selection in 17% of the primary-aim and 18% of
the secondary-aim studies, whereas forward selection was reported
in 6% and 0%, respectively. 18% of all studies investigated the
Table 4. Reporting of candidate predictors.
Reporting and Handling of Candidate Predictors Percentage (n)
Clear definition 87 (59)
Assessment blinded for outcome(s) 75 (51)
Predictor part of outcome 1 (1)
Interaction of predictors testeda 55 (36)
Handling of continuous predictors describedb 67 (43)
Kept linear (continuous) 67 (43)
(Fractional) polynomial transformation or any spline
transformation
19 (12)
Categorised 47 (30)
Dichotomized 33 (21)
Other 3 (2)
Impact studies (n= 3) were excluded from this table as their aim is not to
develop or validate a prediction model, but rather to quantify the effect or
impact of using a prediction model on physicians’ behaviour, patient outcome,
or cost-effectiveness of care relative to not using the model or usual care.
Hence, for this table total n= 68.
aNot applicable for the three external validation studies. Hence, n= 65.
bNot applicable in four studies, because one studied no continuous predictors,
and the others were the three external validation studies. Hence, n= 64. Of
these, handling was unclear in 19 studies, not described in two studies. The sum
43+12+30+21+2 is more than 43 because some studies handled continuous
predictors in two ways (e.g., dichotomizing blood pressure and categorising
body mass index into four categories).
doi:10.1371/journal.pmed.1001221.t004
Table 5. Effective sample size of the included studies
(reflecting statistical power).
Effective Sample Size
Prediction as
Primary Aim
(n=96 Models)a
Prediction as
Secondary Aim
(n=28 Models)a
Considering only the
predictors in the final model
,5 8 (8) 0 (0)
5–10 6 (6) 25 (7)
10–15 11 (11) 4 (1)
.15 63 (60) 46 (13)
Number of participants or
events not described
11 (11) 25 (7)
Considering all candidate
predictorsb
,5 7 (7) 14 (4)
5–10 7 (7) 11 (3)
10–15 0 (0) 0 (0)
.15 19 (18) 11 (3)
Number of candidate
predictors not described
67 (64) 64 (18)
Numbers are column percentages, with absolute numbers in parentheses. For
continuous outcomes, the effective sample size is the number of participants
divided by the number of predictors; for dichotomous outcomes, the effective
sample size is the number of participants in the smallest category divided by
the number of predictors; for time-to-event outcomes, the effective sample size
is the number of events divided by the number of predictors.
aExcluding impact and external validation studies, because they require very
different statistical power calculations.
bThe number of candidate predictors was the total number of degrees of
freedom (i.e., the sum of all candidate predictors, interactions, and dummy
variables).
doi:10.1371/journal.pmed.1001221.t005
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added value of specific predictors, and 42% included predictors
regardless of statistical significance.
The most commonly reported criterion for predictor selection
in multivariable models was a p-value of ,0.05, used in 18% of
all studies (and in 26% of the studies that indeed applied
predictor selection in multivariable analyses). Other criteria, such
as Akaike’s Information Criterion or R2, were used much less
frequently.
Missing Values
Missing values in clinical study data rarely occur completely at
random. Commonly missing values are related to observed
participant or disease characteristics. Exclusion of participants
with missing values will therefore not only lead to loss of statistical
power, but often also to biased results [10,12,13,23,24,57,58].
Imputation, notably multiple imputation, of missing values is often
advocated to preserve power and obtain less biased results, on the
assumption that the reason for the missing data is not entirely due
to non-observed information (i.e., data are not ‘‘missing not at
random’’). When there are few missing observations, for example
,5% of the individual values in the data, sometimes simple
methods are advocated such as single imputation or imputation of
the mean [13,23,59].
Occurrence and handling of missing values was not described or
was unclear in 38% of all studies (Table 7). If reported, it was
mostly reported by ‘‘missing values per predictor’’ (58%). Loss to
follow-up was reported in 46% of the studies where this was
applicable.
Analysis of participants with complete data (i.e., complete case
analysis) was performed in the vast majority of studies. It is likely
that the studies that did not or unclearly reported the method of
handling missing values applied a complete case analysis as well.
By comparison, multiple imputation, the most rigorous strategy for
dealing with missing values, was used in only 8% of all studies.
With the missing indicator method, a dummy or indicator (0/1)
variable is created for every predictor with missing values, with 1
indicating a missing value for the original predictor and 0
indicating an observed value. This predictor is then included as a
separate predictor in the multivariable analysis. Even though this
method is known to lead to biased results in almost all
observational studies [13,23,60–62], it was still used in 13% of
the studies investigated here.
Presentation of Results
Most guidelines, such as the STROBE guidelines for the
reporting of observational studies or the REMARK guidelines for
Table 6. Method of predictor selection, stratified by whether prediction was the primary or secondary study aim.
Selection Method
Prediction as
Primary Aim (n=48)
Prediction as Secondary
Aim (n=17) Total (n=65)
Selection of predictors for inclusion in the multivariable analysis
Not based on statistical analysisa,b
Method described 75 (36) 47 (8) 68 (44)
Literature based 71 (34) 29 (5) 60 (39)
A priori hypothesis/clinical reasoning 29 (14) 29 (5) 29 (19)
Based on statistical analysis
Screening by univariable analysis 13 (6) 24 (4) 15 (10)
Method of predictor selection used within multivariable analysisa
Backward selection 17 (8) 18 (3) 17 (11)
Forward selection 6 (3) 0 (0) 5 (3)
Added value of a specific predictor to existing predictors or modelc 25 (12) 0 (0) 18 (12)
All predictors included regardless of statistical significance 40 (19) 47 (8) 42 (27)
Similar predictors combinedd 17 (8) 6 (1) 11 (7)
Method not described 27 (13) 35 (6) 29 (19)
Criterion for selection of predictors in multivariable analysese
p-Value cut-off at ,0.05 or lower 21; 29 (10) 12; 18 (2) 18; 26 (12)
p-Value cut-off higher than 0.05 4; 6 (2) 12; 18 (2) 6; 9 (4)
Akaike’s Information Criterion 4; 6 (2) 0; 0 (0) 3; 4 (2)
Bayesian Information Criterion 2; 6 (1) 6; 9 (1) 3; 4 (2)
Explained variance (R2) 4; 6 (2) 0; 0 (0) 3; 4 (2)
Change in C-statistic 10; 14 (5) 0; 0 (0) 9; 13 (6)
Numbers are column percentages, with absolute numbers in parentheses. Impact and external validation studies (n=6) were excluded from this table as these issues
are not applicable for these type of studies. Hence, n=65.
aMore than one method may be used within a study; percentages do not add up to 100%.
bPercentage (number) of studies that reported the applied method for selecting which predictors were included in the multivariable analyses, if it was not based on
statistical analysis (i.e., univariable predictor–outcome associations).
cPredictor inclusion in multivariable model was pre-specified, as the specific aim was to quantify the added value of a new predictor to existing predictors.
dFor example, systolic and diasystolic blood pressure combined to mean blood pressure.
eFor the items below, two percentages are given. The first percentage includes all studies (i.e., 48 predictor finding studies, 17 model development studies, or 65 total);
the second is the percentage of all studies that applied some type of predictor selection in the multivariable analysis (35 predictor finding studies, 11 model
development studies, and 46 total; the excluded studies did not apply any predictor selection in the multivariable analysis but simply pre-specified the final model).
doi:10.1371/journal.pmed.1001221.t006
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tumour marker prognostic studies, specifically advise investigators
to report both unadjusted results (i.e., from univariable analysis,
yielding the association of each candidate predictor with the
outcome) and adjusted results (i.e., from a multivariable analysis)
[4,38,63]. Presenting results from both analyses allows readers
insight in the predictor selection strategies and allows them to
determine the influence of the adjustment for other predictors.
For prediction studies that apply predictor selection methods in
the multivariable analyses, the presentation of a ‘‘full’’ model, a
model that includes all predictors considered, may therefore be
valuable.
Few studies reported adjusted (20%) or unadjusted (18%)
results of the full model with all candidate predictors considered
(Table 8). The majority, 65% of the predictor finding and 79% of
the model development studies, reported the predictor coeffi-
cients or effect estimates of the model after predictor selection
(the final model).
Model Performance and Internal and External Validity
The assessment of the predictive performance of a prediction
model is important for understanding how predictions from the
model correspond to the observed outcomes. Predictive perfor-
mance of a model can be assessed on the same data that was used
to generate the results (referred to as the apparent performance in
the development dataset), or in random (cross-validated) subsam-
ples of the development dataset, or using resampling techniques
(like bootstrapping), all referred to as internal validation of the
performance of the prediction model [2,8,10,48,64,65]. Quanti-
fying or validating a model’s predictive performance in new
subject data (i.e., subjects other than those used for the model
Table 7. Handling of missing values, stratified by whether prediction was the primary or secondary study aim.
Reporting and Handling of Missing Values
Prediction as
Primary Aim
(n=48)
Prediction as
Secondary Aim
(n=17)
External
Validation Studies
(n=3)
Impact
Studies
(n=3) Total (n=71)
Reporting of missing dataa
Not reported or unclear 35 (18) 53 (9) 0 (0) 0 (0) 38 (27)
Number of participants with missing values 23 (11) 12 (2) 67 (2) 0 (0) 21 (15)
Number of missing values per predictor 60 (29) 47 (8) 33 (1) 100 (3) 58 (41)
Number lost to follow-upb 40 (16) 50 (7) 50 (1) 100 (3) 46 (27)
Methods used for handling of missing datac
Complete case analysisd 71 (33) 53 (9) 67 (2) 33 (1) 65 (45)
Predictor with missing values omitted 2 (1) 12 (2) 0 (0) 0 (0) 4 (3)
Missing indicator method 14 (7) 12 (2) 0 (0) 0 (0) 13 (9)
Single imputation 2 (1) 6 (1) 0 (0) 0 (0) 3 (2)
Multiple imputation 10 (5) 0 (0) 0 (0) 0 (0) 7 (5)
Sensitivity analysise 6 (3) 24 (4) 0 (0) 0 (0) 10 (7)
Not reported or unclear 50 (23) 65 (11) 33 (1) 67 (2) 54 (37)
Numbers are column percentages, with absolute numbers in parentheses.
aSome studies reported more than one item. Hence, percentages do not add up to 100%.
bCross-sectional studies were excluded for this item (item not applicable).
cMore than one method could be applied. Hence, the percentages do not add up to 100%. Items were not applicable for two primary-aim studies that had no missing
values. Hence, total n= 69.
dOnly participants with completely observed data were analysed.
eFor example: in a diagnostic study [73], the investigators assumed that among participants who did not undergo follow-up colonoscopy, the detection rates for any
adenoma and for an advanced adenoma ranged from half to twice the rates among participants who did undergo follow-up colonoscopy.
doi:10.1371/journal.pmed.1001221.t007
Table 8. Presentation of the results, stratified by type of prediction study.
Type of Result Presented
Predictor Finding
Studies (n=51)
Development
Studies (n=14) Total (n=65)a
Unadjusted (univariable) candidate predictor-outcome association 18 (9) 21 (3) 18 (12)
Unadjusted association only of the predictors eventually included in the final model(i.e., after
predictor selection)
37 (19) 29 (4) 35 (23)
Adjusted associations of each predictor in full multivariable model 18 (9) 29 (4) 20 (13)
Adjusted associations of each predictor in final multivariable model 65 (33) 79 (11) 68 (44)
Simplified risk score/nomogram/score chart 4 (2) 36 (5) 11 (7)
Numbers are column percentages, with absolute numbers in parentheses. Impact and external validation studies (n=6) were excluded from this table as these items
were not applicable. Hence, total n= 65.
aThe percentages do not add up to 100%, because studies reported univariable and multivariable models. Further, all studies reporting the full model also reported the
final model.
doi:10.1371/journal.pmed.1001221.t008
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development or internal validation) is the most rigorous form of
model validity assessment and is referred to as external validation
[8,10,32,64,66].
In prediction research, two main types of prediction perfor-
mance measures are usually distinguished: calibration, which is the
agreement between predicted outcome and observed outcome,
and discrimination, which is the ability to separate participants
with and without the outcome of interest [13,67]. In addition,
overall measures for discrimination and calibration (e.g., the R2
and Brier scores) may also be reported.
Calibration was reported in only a few studies (Table 9). If done,
the Hosmer-Lemeshow statistic was the most often reported
calibration measure. Discrimination was assessed with the C-
statistic or area under the receiver operating characteristic (ROC)
curve in 12% of the predictor finding and, as expected, 80% of the
model development and external validation studies. R2 and Brier
score were reported in very few studies. Internal validation was
performed in 33% (n=5) of the 14 model development studies,
and external validation in only four studies.
Discussion
We have described the state of current prediction research, and
highlighted aspects that clearly need improvement. We assessed
the reporting and methods in all clinical prediction studies
published in six high-impact general medical journals in 2008.
Our investigation found that among the 71 prediction studies
identified, the vast majority were predictor finding studies (n=51),
followed by model development studies (n=14). External valida-
tion and model impact studies were rare (n=6). Study design,
participant selection, definitions of outcomes and predictors, and
predictor selection were generally well reported. However,
improvements are clearly needed, both in conduct and in
reporting of the following: how predictors and outcomes are
assessed (with a focus on mutual blinding); the handling of
continuous predictors; whether predictor interactions are studied;
statistical power and effective sample size considerations; occur-
rence and handling of missing data; the presentation of the results
in both the univariable and multivariable analysis; and the
methods used to quantify and notably validate the predictive
performance of prediction models.
We found that 14 studies developed new prediction models (of
which three included an external validation). Three studies
externally validated models, and three investigated the impact of
an existing prediction model. Various reports have indicated that
in prediction modelling research there is an unfortunate practice of
developing new models instead of externally validating or updating
existing models [8–10,15,29,36,48]. However, we found a similar
number of model development studies (n=14), and studies that
aimed to evaluate an existing model (n=6+3).
We do acknowledge that various basic items are well described
and reported in prediction studies, for example aim, participant
selection, inclusion and exclusion criteria, and design. These items
have been identified as important in several well-known guidelines
for reporting of clinical research [4,38–41]. Journals systematical-
ly, and apparently effectively, refer to these guidelines in their
‘‘instructions for authors’’. However, sample size considerations,
applied statistical methods, and procedures for dealing with
missing data were poorly reported despite being highlighted in
several reporting guidelines. Poor reporting of sample size
rationale has also been observed by others [3,21,68]. Further,
we could not assess statistical power or effective sample size for
many studies because of inadequate reporting of the number of
candidate predictors.
In descriptions of participant selection, it often remained
unclear whether participants were included in an unbiased way,
notably with respect to refusals and whether all consecutive eligible
participants were included. In contrast to randomized therapeutic
trials, flow diagrams were hardly ever presented in prediction
studies, which may reflect the difficulties of using these in
prediction modelling studies because of the use of multiple
analyses. The REMARK guidelines for prognostic tumour marker
studies recommend using a REMARK profile table instead of a
flow diagram [69].
Good reporting of how candidate predictors were pre-selected
in our review compares favourably with other reviews
[15,20,21,29,33,35,36,48]. However, the methods used for further
predictor selection during the statistical analyses were poorly
reported. Univariable pre-selection and predictor selection in
Table 9. Model performance measures, stratified by type of
prediction study.
Performance measure
Predictor
Finding
Studies
(n=51)
Development
(n=14) and
External
Validation
(n=1) Studies
Combineda
Total
(n=66)a
Calibration measures
Calibration plot 0 (0) 27 (4) 6 (4)
Calibration intercept
and slope
0 (0) 0 (0) 0 (0)
Hosmer-Lemeshow statistic 4 (2) 27 (4) 9 (6)
Discrimination measures
C-statistic/AUC-ROC 12 (6) 80 (12) 27 (18)
Classification
NRI 2 (1) 40 (6) 11 (7)
Sensitivity/specificity 2 (1) 7 (1) 3 (2)
Other 2 (1) 33 (5) 9 (6)
Overall performance
measures
Brier score 0 (0) 7 (1) 2 (1)
R2 8 (4) 13 (2) 9 (6)
Validity assessment
Apparentb 18 (9) 60 (9) 27 (18)
Internal with jack-knife 0 (0) 7 (1) 2 (1)
Internal with (random) split
sample
0 (0) 13 (2) 3 (2)
Internal with bootstrapping
techniques
4 (2) 13 (2) 6 (4)
External 0 (0) 27 (4) 6 (4)
Numbers are column percentages, with absolute numbers in parentheses. The
percentages sometimes do not add up to 100% because development studies
commonly reported more than one performance measure or validity
assessment.
aImpact studies (n= 3) were excluded since all items were not applicable.
Additionally, two external validation studies were excluded because they
evaluated risk stratification tools that did not provide predicted probabilities
(the Manchester triage system [74] and predictive life support tools [75]). Hence,
almost all items were not applicable. Hence, for this table total n= 66 studies.
bThe predictive performance (e.g., C-statistic, calibration, or net reclassification
index) of the prediction model as estimated from the same data from which the
model was developed.
AUC-ROC, area under the receiver operation characteristic curve; NRI, net
reclassification index.
doi:10.1371/journal.pmed.1001221.t009
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multivariable analyses based solely on p-values (with a ,0.05 cut-
off) was often used in predictor finding and model development
studies. This approach may notably be problematic with low
numbers of events and many candidate predictors. As the exact
number of events per candidate predictor could almost never be
assessed, it was not possible to determine whether reported results
were indeed subject to overfitting or optimistic predictive
performances. Several studies, however, did not rely exclusively
on these methods for predictor selection, but rather also, as is
recommended, included established predictors in their model
regardless of statistical significance in their dataset.
Most studies reported the occurrence of missing data but did not
report sufficient detail. Complete case analysis was by far the most
commonly used approach to handle missing values, despite many
methodological recommendations to do otherwise [10,12,13,
23,24,57,58]. Recommended methods, such as multiple imputa-
tion, were applied and reported in very few studies, although this
may be due to the fact that consensus in recommending these
methods was arrived at only recently. As the reasons for missing
values were insufficiently described in most studies that applied a
complete case analysis, it was impossible to judge whether
imputation methods would indeed have been appropriate.
Most studies correctly reported the (adjusted) predictor effects
derived from the final multivariable analyses. Only a few studies also
reported results of the univariable analyses, which is often a useful
comparator. As noted in the REMARK guidelines [4], a compre-
hensive reporting of both univariable and multivariable analyses
would allow readers to evaluate the adjustment for other predictors.
We observed much variation in the reporting of predictive
performance measures. C-statistics or area under the ROC curves
were the most frequently reported discrimination statistics,
whereas measures of calibration (such as calibration slope) and
overall measures of fit were rarely reported. Calibration measures
are essential in model validation studies, to judge whether the
predicted probabilities indeed match observed frequencies of the
outcome under study.
The majority of model development studies reported predictive
performance in the development data only. This apparent model
performance, however, is generally too optimistic, as the model
has been tailored to the dataset at hand. Overfitting is even more
likely when the number of candidate predictors is large relative to
the effective sample size [10,12,70]. The extent of this optimism
may be estimated with so-called internal validation techniques
[10,12,43,70], but use of these techniques was rare. Similarly, only
a very few model development studies reported an external
validation of the model in the same paper. Accordingly, the
generalisability of the performance of these reported models,
especially in studies where prediction was the primary aim, is
difficult to evaluate.
To further frame our results, a few issues need to be addressed.
We examined prediction studies published in six high impact
journals, likely representing higher quality studies. Reporting may
have improved since 2008, although this is unlikely since no major
reporting guidelines for this type of research have been produced
recently. The recently published GRIPS statement and existing
guidelines such as the REMARK guidelines, though focussed on
specific types of studies, may improve reporting of future
prediction research [4,71]. We note that our work assessed
researchers’ reporting and statistical methods in modelling, and
not necessarily the appropriateness of the design and conduct of
the studies. Conduct of prediction research may be better than
reported in the papers, since journals impose limits on the lengths
of papers. It is important to note that a methodologically weak or
statistically underpowered study is still a poor quality study,
whether or not it is well reported. However, if it is poorly reported,
then the reader will be unable to gauge its relevance and reliability.
To conclude, we identified poor reporting and poor methods in
many published prediction studies, which limits the reliability and
applicability of the published findings. However, encouraging
findings included the frequent use of prospective studies, and
adequate description of participant selection, predictor and
outcome definitions, and the process for (pre)selection of candidate
predictors. Improvement is clearly needed in blinding of assessment
of outcomes for predictor information, many aspects of data
analysis, the presentation of results of multivariable analyses, and
the methods used to quantify and validate the predictive perfor-
mance of a developed prediction model. Only a very small minority
of the papers involved the most useful approaches in predicting
participant clinical outcomes, namely, external validations or
impact assessments of a previously developed prediction model.
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Editors’ Summary
Background. There are often times in our lives when we
would like to be able to predict the future. Is the stock
market going to go up, for example, or will it rain tomorrow?
Being able predict future health is also important, both to
patients and to physicians, and there is an increasing body of
published clinical ‘‘prediction research.’’ Diagnostic predic-
tion research investigates the ability of variables or test
results to predict the presence or absence of a specific
diagnosis. So, for example, one recent study compared the
ability of two imaging techniques to diagnose pulmonary
embolism (a blood clot in the lungs). Prognostic prediction
research investigates the ability of various markers to predict
future outcomes such as the risk of a heart attack. Both types
of prediction research can investigate the predictive prop-
erties of patient characteristics, single variables, tests, or
markers, or combinations of variables, tests, or markers
(multivariable studies). Both types of prediction research can
include also studies that build multivariable prediction
models to guide patient management (model development),
or that test the performance of models (validation), or that
quantify the effect of using a prediction model on patient
and physician behaviors and outcomes (impact assessment).
Why Was This Study Done? With the increase in
prediction research, there is an increased interest in the
methodology of this type of research because poorly done
or poorly reported prediction research is likely to have
limited reliability and applicability and will, therefore, be of
little use in patient management. In this systematic review,
the researchers investigate the reporting and methods of
prediction studies by examining the aims, design, participant
selection, definition and measurement of outcomes and
candidate predictors, statistical power and analyses, and
performance measures included in multivariable prediction
research articles published in 2008 in several general medical
journals. In a systematic review, researchers identify all the
studies undertaken on a given topic using a predefined set
of criteria and systematically analyze the reported methods
and results of these studies.
What Did the Researchers Do and Find? The researchers
identified all the multivariable prediction studies meeting
their predefined criteria that were published in 2008 in six
high impact general medical journals by browsing through
all the issues of the journals (a hand search). They then
scored the methods and reporting of each study using a
comprehensive item list based on recent recommendations
for the conduct of prediction research (for example, the
reporting recommendations for tumor marker prognostic
studies—the REMARK guidelines). Of 71 retrieved studies, 51
were predictor finding studies, 14 were prediction model
development studies, three externally validated an existing
model, and three reported on a model’s impact on
participant outcome. Study design, participant selection,
definitions of outcomes and predictors, and predictor
selection were generally well reported, but other method-
ological and reporting aspects of the studies were subop-
timal. For example, despite many recommendations, contin-
uous predictors were often dichotomized. That is, rather
than using the measured value of a variable in a prediction
model (for example, blood pressure in a cardiovascular
disease prediction model), measurements were frequently
assigned to two broad categories. Similarly, many of the
studies failed to adequately estimate the sample size needed
to minimize bias in predictor effects, and few of the model
development papers quantified and validated the proposed
model’s predictive performance.
What Do These Findings Mean? These findings indicate
that, in 2008, most of the prediction research published in
high impact general medical journals failed to follow current
guidelines for the conduct and reporting of clinical predic-
tion studies. Because the studies examined here were
published in high impact medical journals, they are likely
to be representative of the higher quality studies published
in 2008. However, reporting standards may have improved
since 2008, and the conduct of prediction research may
actually be better than this analysis suggests because the
length restrictions that are often applied to journal articles
may account for some of reporting omissions. Nevertheless,
despite some encouraging findings, the researchers con-
clude that the poor reporting and poor methods they found
in many published prediction studies is a cause for concern
and is likely to limit the reliability and applicability of this
type of clinical research.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001221.
N The EQUATOR Network is an international initiative that
seeks to improve the reliability and value of medical
research literature by promoting transparent and accurate
reporting of research studies; its website includes infor-
mation on a wide range of reporting guidelines including
the REMARK recommendations (in English and Spanish)
N A video of a presentation by Doug Altman, one of the
researchers of this study, on improving the reporting
standards of the medical evidence base, is available
N The Cochrane Prognosis Methods Group provides addi-
tional information on the methodology of prognostic
research
Reporting and Methods in Prediction Research
PLoS Medicine | www.plosmedicine.org 13 May 2012 | Volume 9 | Issue 5 | e1001221
